Scientists test new drug to Fine-Tune blood clotting treatments
Knowledge-focused
Ongoing
This early-stage study aims to understand how a new investigational drug, VMX-C001, interacts with standard blood thinners (anticoagulants) in the body. It involves 16 healthy volunteers who will receive the new drug alongside common medications like heparin and rivaroxaban. Rese…
Phase: PHASE1 • Sponsor: VarmX B.V. • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC